Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Kirin to Acquire Hematech, LLC - Aims to Accelerate Development of Fully Human Polyclonal Antibody Medicines
- Tokyo, Japan, July 25, 2005 - JCN Newswire - Kirin Brewery Company, Limited (TSE: 2503; Nasdaq: KNBWY) today announced that on July 18, 2005 it had closed on the acquisition of substantially all of Hematech, LLC. The agreement was signed by Katsuhiko Asano, president of Pharmaceutical Division for Kirin,...
- Research articles 2005-07-26
Additional Resources
- Hematech Receives Second $3 Million Congressional Appropriation
- SIOUX FALLS, S.D. -- Hematech, LLC announced today that the House and Senate conference committee on the FY 2005 Defense Department Appropriations bill has included $3 million to support Hematech's antibody development programs. The funding will be administered by the Army's Joint Vaccine Acquisition Program JVAP. This is the second...
- Research articles 2004-07-28
- Hematech Wins $3.3 M U.S. Government Contract through DynPort Vaccine Company LLC to Develop Protective Antibodies against Potential Bioweapons Agent, Botulinum Neurotoxins
- Business/Technology Editors & Health/Medical Writers SIOUX FALLS, S.D.--BUSINESS WIRE--Oct. 30, 2002 Hematech, LLC announced today that it will receive $3.3 million in government funding to develop a bovine system for producing human polyclonal antibodies against botulinum neurotoxins. Botulinum neurotoxins are the most poisonous natural biological substances known and...
- Research articles 2002-10-30
- Hematech Achieves Milestone in Development of Human Polyclonal Antibody Production System
- Health/Medical Writers BIOWIRE2K SIOUX FALLS, S.D.--BUSINESS WIRE--June 2, 2004 - Gene targeting technology used to remove bovine antibody genes and genes for prion proteins that can cause mad cow disease - - Technology published in Nature Genetics - Hematech, LLC and Kirin Brewery Company, Ltd,...
- Research articles 2004-06-02
- Hematech Appoints David L. Danley, Ph.D. to its Board of Directors
- SIOUX FALLS, S.D. -- Hematech, LLC announced today the appointment of David L. Danley, Ph.D. to its Board of Directors. Dr. Danley brings to the Board more than 20 years of experience in medical and biotech research as well as developing and managing biodefense initiatives for industry and the Department...
- Research articles 2005-02-11
- First Prion-Free Cows Reported in Nature Biotechnology
- Hematech Scientific Team "Knock Out" Prion Protein Gene in Cattle SIOUX FALLS, S.D. & TOKYO -- Hematech, Inc (a subsidiary of the Kirin Brewery Company, Ltd) and Kirin Brewery Company, Ltd, announced today, in a report published in Nature Biotechnology, the production of healthy prion protein-knockout cows. Prion protein...
- Research articles 2006-12-31
- Researchers Create Potential New Source of Human Antibodies from Cows; Report in Nature Biotechnology Highlights Successful Production of Human Antibodies in Cloned Calves
- Business Editors/Health/Medical Writers NOTE TO MEDIA: Multimedia assets available SIOUX FALLS, S.D.--BW HealthWire--Aug. 12, 2002 Scientists today reported the successful application of proprietary cloning techniques to produce four calves that express a human chromosome fragment coding for the broad range of human antibodies. The research was...
- Research articles 2002-08-12
- << Previous
- page 1 of 1
- Next >>
